Abstract Submission
Call for Abstracts
Abstract Submission Deadline: Closed
Abstract Evaluation Deadline: 6th July 2025
Delegates Communication Date: 10th July 2025
Presentation on Stage - Dates at the Conference:
Free Papers: Friday, 1st August 2025 (9:00 a.m. – 09:45 a.m.)
Awards Papers: Saturday, 2nd August 2025 (9:00 a.m. – 09:40 a.m.)
E-posters on stage Presentation: Saturday, 2nd August 2025 (9:00 a.m. – 09:40 a.m.)
We have abstract submission for the following categories for CosdermIndia 2025:
> Award Papers
> E-Posters on Stage
> Free Papers
Kindly note: CDSI Membership is mandatory to present.
The best paper in each category will receive a certificate and prizes as below:| Category | Eligibility | No. Of Papers Selected | Time Allotted to Present | Prize for 1st Winner | Prize for 2nd Winner |
| Award Papers | Post graduate students & Practising Dermatologists less than 35 years | 5 Papers | 8 mins | Rs. 25,000/- + Certificate | Rs. 20,000/- + Certificate |
| Free Papers | Open to all | 5 Papers | 8 mins | Rs. 10,000/- + Certificate | Rs. 6,000/- + Certificate |
| E-Posters on stage | Post graduate students & Practising Dermatologists less than 35 years | 8 Top E-posters are to be presented on the stage - 3 slides allowed per presenter. Audience Q&A All the other e-posters accepted will be displayed during the conference on a dedicated screen | NA | Rs. 10,000/- + Certificate | Rs. 6,000/- + Certificate |
Terms & Conditions
Please make sure to be fully familiar with the abstract formalities and terms & conditions before sending your abstract- incomplete abstracts or abstracts with formal errors will not be considered!
On acceptance of your abstract Conference registration is compulsory within 3 working days.
On acceptance of your abstract Conference registration is compulsory within 3 working days.
Abstract Guidelines
Please remember: incomplete abstracts or abstracts with formal errors will generally lead to the exclusion of abstracts!
- Abstracts must be submitted as MS-Word or (editable) pdf document.
- Abstracts must be submitted in English using font Times New Roman Font size 12 and must not exceed 250 words. (Excluding title, authors, their affiliations etc.)
- Title should be written using ‘Sentence case’ and should be brief and self-explanatory.
- Avoid abbreviations in the title.
- The Paper or Innovation should not be published anywhere or not presented in previous CDSI conferences.
- The abstract must clearly indicate the following (to be excluded from the word count):
- Abstract title
- Category (Award Papers/ Free Papers/ E-Posters / Innovations)
- Name(s) of the presenting author(s)
- Name(s) of the co authors
- Institute or Affiliation of author(s)
- Structure of abstract: For studies – Title, Type of Study, Introduction & Objectives, Material and methods, Results, Conclusion
- For case report – Title, Introduction, case report, conclusion
- Results and conclusions should be clearly illustrated.
- Refrain from using keywords, graphs, figures, tables or references in the abstract.
- Conflict of interest statement and declaration of conflict is mandatory.
- Use generic names of drugs or its active pharmacological content, avoiding commercial names of drugs/companies
- Abstracts may be reproduced as such, therefore the onus of ensuring proper language, factual accuracy & responsibility of avoiding plagiarism lies with the authors.
- Non-adherence to any guideline may result in an automatic rejection of the abstract.
- Incomplete abstracts or abstracts not following guidelines will not be considered.
- All submitted abstracts shall be checked for grammar carefully by the submitting author.
- Abstract submission Deadline: 30th June 2025
- Abstract submitted after the deadline will not be considered.
- Author or co-author must be registered delegate of Cosdermindia 2025.
- Accepted abstracts will be notified by email only to the primary author.
- Co-authors cannot be added to the submission after the submission deadline has passed. A limit of 10 co-authors can be listed on the original submission.
- Initials and abbreviations which are not in common use should be avoided unless they are essential.
- Abstracts must contain work that has not been published or previously submitted and/or presented at any CDSI meeting before COSDERMINDIA 2025.
- Authors will be notified of the abstract evaluation results by email.
- In case of any queries please contact us on cosdermindia2025@gmail.com or call us on 9870007315 / 9819219787
Speaker Disclosure of Potential Conflicts of Interest
- All presentations must be as free of commercial bias as possible and that any information on commercial products or services shall be based on already generally accepted medical ethics.
- It is also preferred that generic drug names be used wherever possible and that any presentation referring to unlabelled or research-associated commercial products should disclose this situation to session attendees.
Abstract Evaluation
- All abstracts will be evaluated without knowledge of the author’s name. Acceptance or rejection of an abstract will be based on the average grade awarded by the reviewers.
- The abstract should be presented in a way that the contribution of the research to advance knowledge can be assessed.
- The decision of the scientific committee will be final and binding.
- By submitting an abstract, the author confirms that he has read and understood the terms & conditions and accepts them.